|

Dexamethasone Versus Mg Added to Bupivacaine Used in ESPB for Perioperative Pain Control in Patients Undergoing Unilateral Nephrectomy

RECRUITINGN/ASponsored by National Cancer Institute, Egypt
Actively Recruiting
PhaseN/A
SponsorNational Cancer Institute, Egypt
Started2024-05-01
Est. completion2024-11-01
Eligibility
Age18 Years – 65 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06501079

Summary

Aim of the study: The current study aims to compare the effect of adding dexamethasone versus magnesium sulfate to bupivacaine in ultrasound-guided erector spinae plane block on the severity of postoperative pain. Primary Objectives: \- To compare the effect of ESPB without additives to the effect of adding dexamethasone and to the impact of adding magnesium sulfate in the form of post-operative morphine consumption

Eligibility

Age: 18 Years – 65 YearsHealthy volunteers accepted
Inclusion Criteria:

* Adult (18 - 65)
* Patients undergoing unilateral nephrectomy
* ASA II / III

Exclusion Criteria:

* Patient refusal
* Age less than 18 years
* Allergy to any of the studied medications
* Mid line incision
* Bilateral nephrectomy
* Distorted anatomy of the back (e.g. kyphoscoliosis)
* Known neurologic disorders, psychiatric disorder or chronic pain
* Local infection
* Hemodynamic instability

Conditions2

CancerRenal Neoplasm

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.